Literature DB >> 15805336

Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs.

Clare Gilbert1, Alistair Fielder, Luz Gordillo, Graham Quinn, Renato Semiglia, Patricia Visintin, Andrea Zin.   

Abstract

OBJECTIVE: Retinopathy of prematurity (ROP) is a potentially avoidable cause of blindness in children. The proportion of blindness as a result of ROP varies greatly among countries depending on their level of development, being influenced by the availability of neonatal care, neonatal outcomes, and whether effective screening and treatment programs are in place. The objective of this study was to compare characteristics of premature infants who developed severe ROP between 1996 and 2002 in highly developed countries with less developed countries.
METHODS: This was an observational study. A questionnaire was completed by ophthalmologists in countries with low, moderate, and high development rankings (3 highly developed countries and from 10 less well-developed countries) who screen for ROP in which they supplied birth weights and gestational ages (GAs) of infants who were treated for threshold ROP or identified with more advanced stages of the disease. Birth weights and GAs of infants with severe ROP were measured.
RESULTS: The mean birth weights of infants from highly developed countries ranged from 737 to 763 g compared with values ranging from 903 to 1527 g in less developed countries. Mean GAs of infants from highly developed countries ranged from 25.3 to 25.6 weeks compared with 26.3 to 33.5 weeks in less developed countries. A total of 13.0% of 1091 infants from poorly developed countries exceeded United Kingdom screening criteria; 3.6% exceeded a criteria of <34 weeks' GA and/or <1750 g birth weight.
CONCLUSIONS: These findings suggest that larger, more mature infants are developing severe ROP in countries with low/moderate levels of development compared with highly developed countries. ROP screening programs need to use criteria that are appropriate for their local population.

Entities:  

Mesh:

Year:  2005        PMID: 15805336     DOI: 10.1542/peds.2004-1180

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  184 in total

1.  Detection of clinically significant retinopathy of prematurity using wide-angle digital retinal photography: a report by the American Academy of Ophthalmology.

Authors:  Michael F Chiang; Michele Melia; Angela N Buffenn; Scott R Lambert; Franco M Recchia; Jennifer L Simpson; Michael B Yang
Journal:  Ophthalmology       Date:  2012-04-27       Impact factor: 12.079

Review 2.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

3.  ROP and neurodevelopmental disabilities.

Authors:  G E Quinn
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

4.  Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity.

Authors:  A L Ells; G A Gole; P Lloyd Hildebrand; A Ingram; C M Wilson; R Geoff Williams
Journal:  Eye (Lond)       Date:  2013-01-18       Impact factor: 3.775

5.  Impact of Chronic Neonatal Intermittent Hypoxia on Severity of Retinal Damage in a Rat Model of Oxygen-Induced Retinopathy.

Authors:  Kay D Beharry; Charles L Cai; Taimur Ahmad; Sibel Guzel; Gloria B Valencia; Jacob V Aranda
Journal:  J Nat Sci       Date:  2018

6.  Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

Authors:  David Morrison; James Shaffer; Gui-Shuang Ying; Gil Binenbaum
Journal:  J AAPOS       Date:  2018-03-14       Impact factor: 1.220

7.  Validation of the Colorado Retinopathy of Prematurity Screening Model.

Authors:  Emily A McCourt; Gui-Shuang Ying; Anne M Lynch; Alan G Palestine; Brandie D Wagner; Erica Wymore; Lauren A Tomlinson; Gil Binenbaum
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

8.  POSTNATAL SERUM INSULIN-LIKE GROWTH FACTOR I AND RETINOPATHY OF PREMATURITY.

Authors:  Anne K Jensen; Gui-Shuang Ying; Jiayan Huang; Graham E Quinn; Gil Binenbaum
Journal:  Retina       Date:  2017-05       Impact factor: 4.256

9.  Parental perceptions toward digital imaging and telemedicine for retinopathy of prematurity management.

Authors:  Joo-Yeon Lee; Yunling E Du; Osode Coki; John T Flynn; Justin Starren; Michael F Chiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-23       Impact factor: 3.117

10.  Telemedical diagnosis of retinopathy of prematurity: accuracy of expert versus non-expert graders.

Authors:  Steven L Williams; Lu Wang; Steven A Kane; Thomas C Lee; David J Weissgold; Audina M Berrocal; Daniel Rabinowitz; Justin Starren; John T Flynn; Michael F Chiang
Journal:  Br J Ophthalmol       Date:  2009-12-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.